IPO
In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks
Synthetic.com’s publisher and editor, Simons Chase, interviews Matthew McKnight. Matt is the Chief Commercial Officer of Ginkgo Bioworks where h...
DISCOVERIES
How Immune Macrophages Communicate
Students of synthetic biology soon discover that living things are more adaptive and creative than most people ever imagined. According to Perry Marsh...
STARTUPS
Strand Therapeutics Wins NIH CAR-T Cell Immunotherapy Contract
Strand Therapeutics, a privately held biotech company developing next-generation, programmable mRNA therapeutics beyond vaccines, announced last week ...
SCIENCE
Immunotherapy: The Making Of A Revolution
To learn how something works is to understand how it’s built. How it came to be. That’s true not only if you play a guitar or repair motorcycle engine...
